Failure of linezolid therapy for post-neurosurgical meningitis due to Enterococcus faecium.

1. Wierzbowski AK, Hoban DJ, Hisanaga T et al. The use of macrolides in treatment of upper respiratory tract infections. Curr Infect Dis Rep 2005; 7: 175–84. 2. Zhanel GG, Johanson C, Hisanaga T et al. Pharmacodynamic activity of telithromycin against macrolide-susceptible and macrolideresistant Streptococcus pneumoniae simulating clinically achievable free serum and epithelial lining fluid concentrations. J Antimicrob Chemother 2004; 54: 1072–7. 3. Hammerschlag MR, Sharma R. Use of cethromycin, a new ketolide, for treatment of community-acquired respiratory infections. Expert Opin Investig Drugs 2008; 17: 387–400. 4. Wierzbowski AK, Nichol K, Laing N et al. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998–2004). J Antimicrob Chemother 2007; 60: 733–40. 5. Sutcliffe J, Grebe T, Tait-Kamradt A et al. Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother 1996; 40: 2562–6. 6. Hoban DJ, Zhanel GG. Clinical implications of macrolide resistance in community-acquired respiratory tract infections. Expert Rev Anti Infect Ther 2006; 4: 973–80. 7. Canton R, Mazzariol A, Morosini MI et al. Telithromycin activity is reduced by efflux in Streptococcus pyogenes. J Antimicrob Chemother 2005; 55: 489–95.